Renovaro (RENB) said Tuesday that its BioSymetrics unit received a notice of allowance from the US Patent and Trademark Office for a new patent application.
The patent protects novel methods for integrating and harmonizing diverse biomedical data sources in a framework for predictive modeling, according to Renovaro.
Shares of the company jumped 8.8% in recent trading.
Price: 0.33, Change: +0.04, Percent Change: +14.94
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。